Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) EV to CFO (2021)

Updated

Precision Biosciences' (DTIL) EV to CFO stood at 20881.60 in fiscal Q2 2021 (quarter ended Jun 30, 2021), up 683.7% from the prior quarter.

Analysis

Precision Biosciences (DTIL) EV to CFO (2021) Analysis & Trends

On a TTM basis, Precision Biosciences' EV to CFO came in at 20515.43 as of Jun 30, 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Precision Biosciences 165.47 Mn -183.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 20,881.60
Mar 31, 2021 2,664.36
API Access

Precision Biosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=DTIL&period=max&api_key=YOUR_API_KEY